Literature DB >> 22819757

Metabolic adaptations to methionine restriction that benefit health and lifespan in rodents.

Carmen E Perrone1, Virginia L Malloy, David S Orentreich, Norman Orentreich.   

Abstract

Restriction of dietary methionine by 80% slows the progression of aged-related diseases and prolongs lifespan in rodents. A salient feature of the methionine restriction phenotype is the significant reduction of adipose tissue mass, which is associated with improvement of insulin sensitivity. These beneficial effects of MR involve a host of metabolic adaptations leading to increased mitochondrial biogenesis and function, elevated energy expenditure, changes of lipid and carbohydrate homeostasis, and decreased oxidative damage and inflammation. This review summarizes observations from MR studies and provides insight about potential mediators of tissue-specific responses associated with MR's favorable metabolic effects that contribute to health and lifespan extension.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22819757     DOI: 10.1016/j.exger.2012.07.005

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  33 in total

Review 1.  Protein and amino acid restriction, aging and disease: from yeast to humans.

Authors:  Hamed Mirzaei; Jorge A Suarez; Valter D Longo
Journal:  Trends Endocrinol Metab       Date:  2014-08-19       Impact factor: 12.015

Review 2.  Sensing and signaling mechanisms linking dietary methionine restriction to the behavioral and physiological components of the response.

Authors:  Laura A Forney; Kirsten P Stone; Desiree Wanders; Thomas W Gettys
Journal:  Front Neuroendocrinol       Date:  2017-12-21       Impact factor: 8.606

Review 3.  Caloric restriction: beneficial effects on brain aging and Alzheimer's disease.

Authors:  Caroline Van Cauwenberghe; Charysse Vandendriessche; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  Mamm Genome       Date:  2016-05-30       Impact factor: 2.957

Review 4.  Regulation of metabolic health and aging by nutrient-sensitive signaling pathways.

Authors:  Nicole E Cummings; Dudley W Lamming
Journal:  Mol Cell Endocrinol       Date:  2016-11-22       Impact factor: 4.102

5.  Effects of hepatic protein tyrosine phosphatase 1B and methionine restriction on hepatic and whole-body glucose and lipid metabolism in mice.

Authors:  Emma Katherine Lees; Elzbieta Krol; Kirsty Shearer; Nimesh Mody; Thomas W Gettys; Mirela Delibegovic
Journal:  Metabolism       Date:  2014-11-05       Impact factor: 8.694

6.  Cysteine dietary supplementation reverses the decrease in mitochondrial ROS production at complex I induced by methionine restriction.

Authors:  A Gomez; J Gomez; M Lopez Torres; A Naudi; N Mota-Martorell; R Pamplona; G Barja
Journal:  J Bioenerg Biomembr       Date:  2015-03-15       Impact factor: 2.945

7.  Metabolic adaptation of short-living growth hormone transgenic mice to methionine restriction and supplementation.

Authors:  Holly M Brown-Borg; Sharlene Rakoczy; Joseph A Wonderlich; Kurt E Borg; Lalida Rojanathammanee
Journal:  Ann N Y Acad Sci       Date:  2018-04       Impact factor: 5.691

8.  Methionine and choline regulate the metabolic phenotype of a ketogenic diet.

Authors:  Pavlos Pissios; Shangyu Hong; Adam Richard Kennedy; Deepthi Prasad; Fen-Fen Liu; Eleftheria Maratos-Flier
Journal:  Mol Metab       Date:  2013-07-08       Impact factor: 7.422

9.  Dietary Intake of Proteins and Calories Is Inversely Associated With The Oxidation State of Plasma Thiols in End-Stage Renal Disease Patients.

Authors:  Paolo Fanti; Daniela Giustarini; Ranieri Rossi; Sue E D Cunningham; Franco Folli; Khaled Khazim; John Cornell; Elena Matteucci; Shweta Bansal
Journal:  J Ren Nutr       Date:  2015-07-31       Impact factor: 3.655

10.  Mitohormesis: Promoting Health and Lifespan by Increased Levels of Reactive Oxygen Species (ROS).

Authors:  Michael Ristow; Kathrin Schmeisser
Journal:  Dose Response       Date:  2014-01-31       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.